No existen restricciones para su consumo durante el embarazo y la lactancia, ya que esta es una sustancia natural, cuya demanda se incrementa durante el embarazo y adems, forma parte de la leche humana
Risks of GLP-1 Pharmaceutical Drugs Nausea Vomiting Abdominal pain Constipation Heartburn Flatulence Gastritis Acute kidney injury Pancreatitis Gallstones Ileus Medullary thyroid cancer risk As a result of the above adverse effects, interest has grown in natural ways to increase GLP-1 activity through foods, supplements, and lifestyle changes
Presented for research literature review only Park HJ et al
La mejora en la persistencia anual y la disponibilidad normalizada de los frmacos, junto con estrategias de manejo integral de los efectos adversos, perfilan posibles cambios futuros
Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: incretin actions beyond the pancreas
Both are FDA-approved for the management of type 2 diabetes and chronic weight management